Jamieson Wellness (TSE:JWEL) had its target price hoisted by Eight Capital from C$41.00 to C$44.00 in a research note published on Friday, BayStreet.CA reports.
Other analysts also recently issued research reports about the stock. CIBC upped their price target on shares of Jamieson Wellness from C$36.00 to C$42.00 in a report on Monday, August 17th. National Bank Financial upped their price target on shares of Jamieson Wellness from C$37.50 to C$39.75 and gave the company an outperform rating in a report on Monday, August 17th.
Shares of TSE JWEL opened at C$38.53 on Friday. Jamieson Wellness has a 12-month low of C$22.33 and a 12-month high of C$40.25. The company has a market capitalization of $1.53 billion and a PE ratio of 48.28. The company has a debt-to-equity ratio of 64.23, a current ratio of 2.50 and a quick ratio of 1.08. The firm’s 50-day moving average is C$37.95 and its two-hundred day moving average is C$33.20.
About Jamieson Wellness
Jamieson Wellness Inc develops, manufactures, distributes, sells, and markets natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The company offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe Health Solutions Inc brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands.
Further Reading: What is a death cross?
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.